INFLAMMATORY MARKERS AND ADIPOKINES RELATED TO CARDIOVASCULAR RISK AND METABOLIC COMORBIDITIES IN PSORIATIC ARTHRITIS. IN VIVO EFFECTS OF APREMILAST

De La Rosa, I. AriasLepez-Montilla, M. D.Perez-Sanchez, C.Abalos-Aguilera, M. D. C.Ruiz-Ponce, M.Jimenez-Gomez, Y.Escudero, A.Collantes-Estevez, E.Lopez-Pedrera, C.Barbarroja, N.2025-01-072025-01-072018-06-010003-4967https://hdl.handle.net/10668/28250enINFLAMMATORY MARKERS AND ADIPOKINES RELATED TO CARDIOVASCULAR RISK AND METABOLIC COMORBIDITIES IN PSORIATIC ARTHRITIS. IN VIVO EFFECTS OF APREMILASTconference outputopen access10.1136/annrheumdis-2018-eular.62591468-2060https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1030.2.full.pdf444351003074